Back to results
CompletedPhase 2

Effect of Insulin Sensitizer Metformin on AD Biomarkers

NCT01965756

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Pennsylvania, Penn Memory Center

Philadelphia, Pennsylvania, United States

View on ClinicalTrials.gov
Effect of Insulin Sensitizer Metformin on AD Biomarkers — TrialFind